Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 18/3018% below fair value
$310.55+3.74 (+1.22%)
Close on Nov 3, 2026Market cap $119.12BP/E 33.1Yield –
Stryker Operating Income Adjustment by Quarter
Operating Income Adjustment — EU Medical Device Regulation (MDR) Costs ($M) ($M)
Stryker Operating Income Adjustment: $6M in Q3 2026, down 45.5% from a year earlier.
Latest, Q3 2026
6
Period ended Sep 30, 2026
Change on a year earlier
-45.5%
11 in Q3 2025
History
31 quarters
Since Q1 2019
Sources
31
Documents cited below
Where the Q3 2026 figure comes from
Reported in Stryker Form 8-K Non-GAAP Schedules.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Stryker Operating Income Adjustment ($M), quarterly Q1 2019–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/core-ng-eumdr
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.
See a number that looks wrong?